Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

(300832)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/18/2022 01/19/2022 01/20/2022 01/21/2022 01/24/2022 Date
46.13 46.32 46.45 43.38 43.11 Last
5066878 2310797 2478838 3937603 1286770 Volume
-3.72% +0.41% +0.28% -6.61% -0.62% Change
Estimated financial data (e)
Sales 2021 2 808 M 444 M 444 M
Net income 2021 1 011 M 160 M 160 M
Net Debt 2021 - - -
P/E ratio 2021 33,8x
Yield 2021 1,20%
Sales 2022 3 617 M 572 M 572 M
Net income 2022 1 405 M 222 M 222 M
Net Debt 2022 - - -
P/E ratio 2022 24,3x
Yield 2022 -
Capitalization 33 913 M 5 350 M 5 362 M
Capi. / Sales 2021 12,1x
Capi. / Sales 2022 9,38x
Nbr of Employees 1 949
Free-Float 9,92%
More Financials
Company
Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic... 
More about the company
Ratings of Shenzhen New Industries Biomedical Engineering Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021SHENZHEN NEW INDUSTRIES BIOMEDICAL E : 300832) added to S&P Global BMI Index
CI
2021SHENZHEN NEW INDUSTRIES BIOMEDICAL E : 300832) added to FTSE All-World Index
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces New Appointments
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces 2020 Final Profit Di..
CI
2021Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subjec..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution ..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Proposes Cash Dividend for the..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces 2020 Interim Distrib..
CI
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for the..
CI
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. Proposes Cash Dividend for the..
CI
More news
News in other languages on SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. annonce le plan de distributio..
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. annonce un plan de distributio..
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. propose un dividende en espèce..
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. annonce la mise en ťuvre d'un ..
2020Shenzhen New Industries Biomedical Engineering Co., Ltd. approuve un dividende en espèc..
More news
Chart SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Duration : Period :
Shenzhen New Industries Biomedical Engineering Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 43,38 CNY
Average target price 60,87 CNY
Spread / Average Target 40,3%
EPS Revisions
Managers and Directors
Wei Rao Chairman & General Manager
Chen Liu Ding Chief Financial Officer & Deputy General Manager
Deng Ke Liu Chairman-Supervisory Board
Hong Zhou Independent Director
Dai Na Wang Independent Director
Sector and Competitors